4//SEC Filing
BIOMET INC 4
Accession 0000769993-07-000904
CIK 0000351346operating
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 8:59 PM ET
Size
13.6 KB
Accession
0000769993-07-000904
Insider Transaction Report
Form 4
BIOMET INCBMET
Fernandes Sean
Director
Transactions
- Sale
Common Shares
2007-08-14$45.57/sh−477$21,737→ 123,805 total(indirect: See footnotes) - Purchase
Common Shares
2007-08-16$45.57/sh+477$21,737→ 124,282 total(indirect: See footnotes)
Holdings
- 1,400(indirect: See footnotes)
Security Based Swap (put equivalent)
Exp: 2017-04-07→ Common Shares (1,400 underlying) - 3,100(indirect: See footnotes)
Call Option (right to purchase)
Exercise: $45.00Exp: 2009-01-17→ Common Shares (3,100 underlying) - 20,200(indirect: See footnotes)
Security Based Swap (put equivalent)
Exp: 2017-04-10→ Common Shares (20,200 underlying)
Footnotes (6)
- [F1]The Reporting Person is currently a vice president of Goldman, Sachs & Co. ("Goldman Sachs"). Goldman Sachs is a wholly-owned subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). Goldman Sachs is affiliated with private equity funds that hold equity interests in LVB Acquisition Holding, LLC, the indirect beneficial owner of 208,324,725 common shares, no par value (the "Common Shares") of Biomet, Inc. (the "Company"), including 5,723,595 Common Shares beneficially owned by Dr. Dane A. Miller and Mary Louise Miller that are subject to a voting agreement with LVB Acquisition, Inc., a subsidiary of LVB Acquisition Holding, LLC. In addition, Goldman Sachs and other wholly-owned subsidiaries of GS Group may be deemed to directly beneficially own 124,282 Common Shares.
- [F2]The Common Shares reported herein as indirectly purchased and sold were beneficially owned directly by Goldman Sachs. Without admitting any legal obligation, Goldman Sachs will remit appropriate profits, if any, to the Company.
- [F3]The Reporting Person disclaims beneficial ownership of all of the securities reported on Table I and Table II of this Form 4, including the Common Shares that are or may be beneficially owned by LVB Acquisition Holding, LLC, Goldman Sachs, other wholly-owned subsidiaries of GS Group and any of their affiliated funds.
- [F4]Immediately exercisable.
- [F5]The securities reported herein are directly beneficially owned by Goldman Sachs.
- [F6]Goldman Sachs International ("GSI"), a wholly-owned subsidiary of GS Group, entered into security-based swap agreements in the form of contracts for differences under which GSI is obligated to make payments to its counterparty, or GSI's counterparty is obligated to make payments to GSI, as the case may be, based on changes in the price of Common Shares and any declared dividends. In addition, the counterparty is obligated to make floating rate payments to GSI based on the notional size of the transaction.
Documents
Issuer
BIOMET INC
CIK 0000351346
Entity typeoperating
IncorporatedIN
Related Parties
1- filerCIK 0000351346
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 8:59 PM ET
- Size
- 13.6 KB